Search Results - "VISWANATHAN, Avinash"

Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma by Velcheti, Vamsidhar, Kasai, Yumi, Viswanathan, Avinash K, Ritter, Jon, Govindan, Ramaswamy

Get more information

Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1 by MIN WANG, VIKIS, Haris G, DE ANDRADE, Mariza, PING YANG, WIEST, Jonathan S, FAIN, Pamela R, SCHWARTZ, Ann G, GAZDAR, Adi, MINNA, John, GABA, Colette, ROTHSCHILD, Henry, MANDAL, Diptasri, YIAN WANG, KUPERT, Elena, SEMINARA, Daniela, YAN LIU, VISWANATHAN, Avinash, GOVINDAN, Ramaswamy, ANDERSON, Marshall W, MING YOU, DONGMEI JIA, DAOLONG WANG, BIERUT, Laura J, BAILEY-WILSON, Joan E, AMOS, Christopher I, PINNEY, Susan M, PETERSEN, Gloria M

“…In this study, we observed loss of heterozygosity (LOH) in human chromosomal fragment 6q25.1 in sporadic lung cancer patients. LOH was observed in 65% of the…”
Get full text

Drug delivery and toxicity of adjuvant chemotherapy for non-small cell lung cancer (NSCLC): Washington University experience by Velcheti, Vamsidhar, Viswanathan, Avinash K, Baggstrom, Maria Q, Govindan, Ramaswamy

Get more information

Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients by Goodgame, Boone, Viswanathan, Avinash, Zoole, Jennifer, Gao, Feng, Miller, C Ryan, Subramanian, Janakiraman, Meyers, Bryan F, Patterson, Alexander G, Govindan, Ramaswamy

“…Half of all patients with non-small cell lung cancer (NSCLC) are 70 years or older at the time of diagnosis. Surgery is an option for fit elderly patients with…”
Get more information

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity by VIKIS, Haris, SATO, Mitsuo, PINNEY, Susan M, PETERSEN, Gloria M, DE ANDRADE, Mariza, PING YANG, WIEST, Jonathan S, FAIN, Pamela R, SCHWARTZ, Ann G, GAZDAR, Adi, GABA, Colette, ROTHSCHILD, Henry, JAMES, Michael, MANDAL, Diptasri, KUPERT, Elena, SEMINARA, Daniela, VISWANATHAN, Avinash, GOVINDAN, Ramaswamy, MINNA, John, ANDERSON, Marshall W, MING YOU, DAOLONG WANG, YIAN WANG, MIN WANG, DONGMEI JIA, YAN LIU, BAILEY-WILSON, Joan E, AMOS, Christopher I

“…The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI…”
Get full text

The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey by Velcheti, Vamsidhar, Viswanathan, Avinash, Govindan, Ramaswamy

Get more information

Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer by Viswanathan, Avinash, Pillot, Giancarlo, Govindan, Ramaswamy

Get full text

A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer by Goodgame, Boone, Viswanathan, Avinash, Miller, C Ryan, Gao, Feng, Meyers, Bryan, Battafarano, Richard J, Patterson, Alexander, Cooper, Joel, Guthrie, Tracey J, Bradley, Jeffrey, Pillot, Giancarlo, Govindan, Ramaswamy

“…There are no reliable markers to predict recurrence in resected Stage I non-small cell lung cancer (NSCLC). A validated clinical model to estimate the risk of…”
Get full text

A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report by Pillot, Giancarlo A, Read, William L, Hennenfent, Kristin L, Marsh, Sharon, Gao, Feng, Viswanathan, Avinash, Cummings, Kristopher, McLeod, Howard L, Govindan, Ramaswamy

“…We conducted a phase II study of carboplatin and irinotecan in patients with advanced non-small cell lung cancer (NSCLC). In addition, we studied the…”
Get more information